prof. dr. H.W. (Henderik Willem) Frijlink

Professor of Pharmaceutical Technology and Biopharmacy

Research

Postal address:
A Deusinglaan
1
Gebouw 3213, ruimte 0222
Groningen
Netherlands
Phone: +31 50 363 3285Fax: +31 50 363 2500
Publications
  1. Learning from Parkinson's patients: Usability of the Cyclops dry powder inhaler

    Luinstra, M., Isufi, V., de Jong, L., Rutgers, A. W. F., Hagedoorn, P., Puttenstein, J., van Laar, T. & Frijlink, H. W., 3-Jul-2019, In : International Journal of Pharmaceutics. 567, p. 118493

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson's disease

    Luinstra, M., Rutgers, W., van Laar, T., Grasmeijer, F., Begeman, A., Isufi, V., Steenhuis, L., Hagedoorn, P., de Boer, A. & Frijlink, H. W., 21-Jun-2019, In : Therapeutic advances in chronic disease. 10, 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation

    Sibum, I., Hagedoorn, P., Frijlink, H. W. & Grasmeijer, F., 13-May-2019, In : Pharmaceutics. 11, 5, 15 p., 233.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Nasal gene expression changes with inhaled corticosteroid treatment in asthma

    Boudewijn, I. M., Lan, A., Faiz, A., Cox, C. A., Brouwer, S., Schokker, S., Vroegop, S. J., Nawijn, M. C., Woodruff, P. G., Christenson, S. A., Hagedoorn, P., Frijlink, H. W., Choy, D. F., Brouwer, U., Wisman, M., Postma, D. S., Fingleton, J., Beasley, R., van den Berge, M. & Guryev, V., 22-Jun-2019, In : Allergy. 11 p.

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

  5. PH-CONTROLLED PULSATILE DELIVERY SYSTEM, METHODS FOR PREPARATION AND USE THEREOF

    Schellekens, R. C. A. & Frijlink, H. W., 1-Feb-2007, IPC No. A61K 47/ 30 A I, Patent No. WO2007013794, Priority date 29-Jul-2005, Priority No. WO2005NL00559

    Research output: PatentProfessional

View all (374) »

Datasets
  1. Dataset: Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice

    Amssoms, K. (Creator), Born, P. (Creator), Beugeling, M. (Creator), De Clerck, B. (Creator), Van Gulck, E. (Creator), Hinrichs, W. (Creator), Frijlink, E. (Creator), Grasmeijer, N. (Creator), Kraus, G. (Creator), Sutmuller, R. (Creator), Simmen, K. (Creator), Baert, L. (Creator), University of Groningen, 17-Aug-2018

    Dataset

View all (1) »

Prizes
  1. Astellas Foundation 2008-2009

    Erik Frijlink (Recipient), 2008

    PrizeAcademic

  2. Wubbo Ockels Price

    Erik Frijlink (Recipient), 2010

    PrizeAcademic

View all (3) »

Activities
  1. European Journal of Pharmaceutics and Biopharmaceutics (Journal)

    Henderik Frijlink (Editor)
    2015 → …

    Activity: Publication peer-review and editorial workEditorial activityAcademic

  2. European Journal of Pharmaceutical Sciences (Journal)

    Henderik Frijlink (Editor)
    2009 → …

    Activity: Publication peer-review and editorial workEditorial activityAcademic

View all (2) »

Press / Media
  1. "De kennis van nu" interview on national television 09-11-2017

    Erik Frijlink

    09/11/2017

    1 media contribution

    Press/Media: ResearchPopular

  2. Liquorice and cannabis oil

    Erik Frijlink

    08/10/2017

    1 media contribution

    Press/Media: Public Engagement ActivitiesPopular

  3. Kippenboeren willen niet enten

    Erik Frijlink

    16/11/2016

    1 item of media coverage

    Press/Media: ResearchPopular

View all (5) »

View graph of relations

ID: 72917